RSCM
THRX

Rock Springs Capital Management’s Theseus Pharmaceuticals, Inc. Common Stock THRX Stock Holding History

Rock Springs Capital Management’s Portfolio THRX Stock Details THRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-437,329
Closed -$1.18M – 120
2023
Q3 		$1.18M Hold
437,329
– – 0.03% 107
2023
Q2 		$4.08M Hold
437,329
– – 0.1% 91
2023
Q1 		$3.88M Hold
437,329
– – 0.09% 95
2022
Q4 		$2.18M Hold
437,329
– – 0.05% 103
2022
Q3 		$2.54M Hold
437,329
– – 0.07% 107
2022
Q2 		$2.42M Hold
437,329
– – 0.07% 110
2022
Q1 		$5.04M Hold
437,329
– – 0.13% 104
2021
Q4 		$5.54M Buy
+437,329
New +$6.6M 0.13% 116

Other funds holding THRX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

Rock Springs Capital Management's THRX Position: Q4 2023 in Review

Rock Springs Capital Management sold out of Theseus Pharmaceuticals, Inc. Common Stock (THRX) in Q4 2023, closing a stake of 437,329 shares — an estimated $1.18M sold.

Rock Springs Capital Management first reported a position in THRX in Q4 2021 and held it in 8 quarters. The position peaked at $5.54M in Q4 2021. 70 funds tracked by Wall St. Rank hold THRX as of Q4 2023.

  • Rock Springs Capital Management reported no remaining Theseus Pharmaceuticals, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Rock Springs Capital Management sold 437,329 Theseus Pharmaceuticals, Inc. Common Stock shares in Q4 2023, an estimated $1.18M.
  • Rock Springs Capital Management first reported a position in Theseus Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
  • Rock Springs Capital Management's Theseus Pharmaceuticals, Inc. Common Stock position peaked at $5.54M in Q4 2021.
  • 70 funds tracked by Wall St. Rank held Theseus Pharmaceuticals, Inc. Common Stock as of Q4 2023.

Based on Rock Springs Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.